NM_017649.5:c.*11186G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_017649.5(CNNM2):​c.*11186G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.406 in 152,024 control chromosomes in the GnomAD database, including 12,693 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 12693 hom., cov: 32)
Exomes 𝑓: 0.21 ( 1 hom. )
Failed GnomAD Quality Control

Consequence

CNNM2
NM_017649.5 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.272

Publications

21 publications found
Variant links:
Genes affected
CNNM2 (HGNC:103): (cyclin and CBS domain divalent metal cation transport mediator 2) This gene encodes a member of the ancient conserved domain containing protein family. Members of this protein family contain a cyclin box motif and have structural similarity to the cyclins. The encoded protein may play an important role in magnesium homeostasis by mediating the epithelial transport and renal reabsorption of Mg2+. Mutations in this gene are associated with renal hypomagnesemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
NT5C2 (HGNC:8022): (5'-nucleotidase, cytosolic II) This gene encodes a hydrolase that serves as an important role in cellular purine metabolism by acting primarily on inosine 5'-monophosphate and other purine nucleotides. [provided by RefSeq, Oct 2011]
NT5C2 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 45
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.469 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNNM2NM_017649.5 linkc.*11186G>A 3_prime_UTR_variant Exon 8 of 8 ENST00000369878.9 NP_060119.3 Q9H8M5-1
NT5C2NM_001351169.2 linkc.*1306C>T 3_prime_UTR_variant Exon 19 of 19 ENST00000404739.8 NP_001338098.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNNM2ENST00000369878.9 linkc.*11186G>A 3_prime_UTR_variant Exon 8 of 8 1 NM_017649.5 ENSP00000358894.3 Q9H8M5-1
NT5C2ENST00000404739.8 linkc.*1306C>T 3_prime_UTR_variant Exon 19 of 19 1 NM_001351169.2 ENSP00000383960.3 P49902-1

Frequencies

GnomAD3 genomes
AF:
0.406
AC:
61666
AN:
151906
Hom.:
12682
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.388
Gnomad AMI
AF:
0.351
Gnomad AMR
AF:
0.403
Gnomad ASJ
AF:
0.431
Gnomad EAS
AF:
0.486
Gnomad SAS
AF:
0.430
Gnomad FIN
AF:
0.365
Gnomad MID
AF:
0.427
Gnomad NFE
AF:
0.415
Gnomad OTH
AF:
0.416
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.214
AC:
3
AN:
14
Hom.:
1
Cov.:
0
AF XY:
0.200
AC XY:
2
AN XY:
10
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.125
AC:
1
AN:
8
Other (OTH)
AF:
0.500
AC:
2
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.406
AC:
61717
AN:
152024
Hom.:
12693
Cov.:
32
AF XY:
0.404
AC XY:
29986
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.388
AC:
16096
AN:
41466
American (AMR)
AF:
0.403
AC:
6154
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.431
AC:
1496
AN:
3468
East Asian (EAS)
AF:
0.485
AC:
2510
AN:
5172
South Asian (SAS)
AF:
0.429
AC:
2068
AN:
4822
European-Finnish (FIN)
AF:
0.365
AC:
3855
AN:
10554
Middle Eastern (MID)
AF:
0.435
AC:
128
AN:
294
European-Non Finnish (NFE)
AF:
0.415
AC:
28207
AN:
67944
Other (OTH)
AF:
0.418
AC:
884
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1910
3819
5729
7638
9548
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
596
1192
1788
2384
2980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.404
Hom.:
17082
Bravo
AF:
0.408
Asia WGS
AF:
0.423
AC:
1466
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.6
DANN
Benign
0.76
PhyloP100
0.27
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8139; hg19: chr10-104848123; COSMIC: COSV58419314; COSMIC: COSV58419314; API